Trial record 74 of 107 for: "Vascular Hemostatic Disease" | "Doxorubicin"
Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00670631|
Recruitment Status : Completed
First Posted : May 2, 2008
Results First Posted : August 31, 2017
Last Update Posted : August 31, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Guido Tricot, University of Iowa
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Combination Product: tandem autologous transplantation
|Pre-assignment Details||Data not available. Study conducted at University of Utah. Upon PI leaving Utah and coming to the University of Iowa, record NCT00670631 was transferred to Iowa by ClinicalTrials.gov staff. No research activities under NCT00670631 were conducted at Iowa. PRS staff at Iowa and Utah have corresponded and neither party (including PI) have the data.|
Data not available. Study conducted at Utah. Upon PI leaving & coming to Iowa, record was transferred to IA by ClinicalTrials.gov. No research activities under NCT00670631 were conducted at IA. PRS staff have corresponded and neither party have data.